Why ROAS and MER Disagree in Multi-Location Surgical Eye Care

The 8-location refractive group’s quarterly review reports a Google Ads ROAS of 6.4x. The agency frames the number as evidence the campaigns are producing strong returns. The CFO runs an independent number from the financials and reports MER of 3.1x for the same period. The board asks the marketing lead to reconcile the two figures. The marketing lead has no defensible reconciliation because the two metrics measure different things using different denominators.

This is the typical reporting pattern in multi-location ophthalmology PPC. The agency optimizes against ROAS as Google computes it. The CFO governs against MER as the financials compute it. Both numbers are correct in their own frame, and both are misleading when reported in isolation. The 6.4x ROAS overstates Google’s contribution to total revenue because last-touch attribution credits the platform for conversions other channels assisted. The 3.1x MER understates Google’s contribution because it pools the cost of every other channel into the denominator. The reconciliation is the conversation that matters at the board level, and most agencies are not equipped to have it.

How ROAS and MER Measure Different Things

ROAS as Google Ads reports it is platform-ROAS. The numerator is revenue attributed by Google’s attribution model to Google Ads clicks. The denominator is Google Ads spend. The ratio captures the platform view of marketing efficiency, optimized for within-platform decisions like bid strategy, campaign budget allocation, and audience targeting.

MER (Marketing Efficiency Ratio) is total revenue divided by total marketing spend across all channels. The numerator is the practice’s full revenue from financials. The denominator includes Google Ads spend, Meta spend, email platform costs, agency fees, SEO investments, offline marketing, and any other line item that lands under marketing in the chart of accounts. MER captures the whole-business view, optimized for portfolio-level decisions like channel allocation, agency-versus-in-house structure, and total marketing investment.

The two metrics serve different decisions. ROAS answers “which campaign should I shift budget toward inside Google Ads.” MER answers “is the practice’s marketing investment producing returns at the portfolio level.” Reporting only one of them obscures the question the other was built to answer. Pair the metric architecture with CPL versus booked-surgery cost for the lead-quality dimension that compounds with the metric-selection problem. Neither metric is wrong in isolation; both are incomplete without the other in the reporting stack. Neither metric is wrong in isolation; both are incomplete without the other in the reporting stack.

What Healthy MER Ranges Look Like for Surgical Eye Care

Ecommerce MER industry benchmarks run 3 to 5x for healthy accounts. Below 2x triggers review. Healthcare MER benchmarks are less standardized in published sources. For multi-location ophthalmology groups, 4 to 8x MER is typical for mature accounts at steady state. New accounts and accounts in heavy growth investment phases run lower MER as they front-load awareness spend that has not yet produced revenue.

Google Ads ROAS often runs 1.5 to 3 times the MER number because Google counts last-touch conversions as fully attributable to its own platform. The ratio between ROAS and MER is itself a useful diagnostic. As the ratio grows, the platform-side accounting is overstating Google’s contribution and the practice’s other channels are doing more work than the dashboard credits them for. Anchor against the broader subspecialty ranges in our ophthalmology PPC benchmarks reference for the underlying CPC, CVR, and CPA inputs that drive both metrics.

Steady state in a healthy multi-location ophthalmology group looks like this. MER 4 to 8x, calculated quarterly from financials. Platform ROAS reported alongside MER for each major channel. The MER-to-ROAS ratio tracked over time as a diagnostic on attribution drift. The CFO sees both numbers in the quarterly board materials.

Five Red Flags That Your Reporting Is Overstating Marketing Performance

The first red flag is the agency reporting ROAS only and never MER. The platform view dominates the QBR materials. The CFO’s view of marketing efficiency does not appear in any document the agency produces.

The second is MER not calculated because it is “too complex to attribute.” MER is intentionally attribution-agnostic. The complexity argument typically masks the agency’s discomfort with a metric that includes their fees in the denominator.

The third is ROAS reported without explanation of the attribution model. The number appears in the dashboard with no documentation of whether last-click, data-driven, or position-based attribution produced it. Attribution model choice changes ROAS materially, and undocumented attribution is the same as undefined ROAS.

The fourth is the CFO never receiving a marketing-to-revenue view. The financial executive who would catch the misalignment first is not in the reporting cycle. The agency reports up to the marketing lead, who does not have the CFO’s frame of reference.

The fifth is no year-over-year MER trend available. The metric is not tracked on a comparable basis across periods, so the practice cannot tell whether marketing efficiency is improving, holding, or declining at the portfolio level. Pair this audit with good Google Ads management for ophthalmology for the broader four-pillar standard.

How to Stand Up Quarterly MER Reporting in 30 Days

Within the next 15 minutes, pull the practice’s total marketing spend for the most recent complete quarter from finance. Include Google Ads, Meta, agency fees, tool subscriptions, allocated SEO cost, and any offline marketing. Pull total practice revenue for the same quarter from the financials. Divide. The 15-minute calculation produces the first MER number the practice has run.

Within 30 days, document the MER calculation methodology in a one-page artifact. Define the numerator (total practice revenue from financials), the denominator (full marketing spend including agency fees and allocated costs), and the comparison periods (rolling four quarters versus prior four quarters). The methodology should not require attribution modeling. The simplicity is the feature.

Within 60 days, build the quarterly CFO report covering MER alongside platform ROAS for each major channel. The report includes the MER-to-ROAS ratio over time as a diagnostic on attribution drift. The CFO receives the report directly, not filtered through the marketing lead.

Watch the MER-to-ROAS ratio quarter over quarter. As the ratio grows, the platform accounting is overstating Google’s contribution. As the ratio compresses, attribution is being computed more honestly or other channels are doing less than they were credited for. Either direction is informative, and the ratio is the artifact that makes the trend visible.

Why Practices Governing on MER Make Better Channel Decisions

Our view is direct. The practices that govern marketing at MER level make better channel-allocation decisions than those governing at platform-ROAS level. MER forces honest trade-offs between paid and organic. Platform-ROAS encourages spending more on the highest-ROAS platform without acknowledging diminishing returns or channel cannibalization.

Multi-location ophthalmology groups that adopt MER reporting end up with better budget discipline, better channel mix decisions, and better executive alignment between marketing and finance. The work to stand up the metric is bounded. The reporting cadence becomes the governance layer that keeps marketing investment honest at the portfolio level. For the deeper benchmarks reference covering MER ranges and the methodology behind the metric, see the Specialty Eye Care PPC Benchmarks Report.

The discipline compounds annually across every metric that governs the overall marketing investment.